ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc (RCKT)

22.25
1.40
( 6.71% )
Updated: 13:06:59

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
22.25
Bid
22.24
Ask
22.25
Volume
625,379
21.267 Day's Range 22.45
14.89 52 Week Range 32.525
Market Cap
Previous Close
20.85
Open
21.31
Last Trade
4
@
22.25
Last Trade Time
13:06:59
Financial Volume
$ 13,480,239
VWAP
21.5553
Average Volume (3m)
649,679
Shares Outstanding
90,782,211
Dividend Yield
-
PE Ratio
-0.04
Earnings Per Share (EPS)
-2.71
Revenue
-
Net Profit
-245.6M

About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesio... Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Rocket Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RCKT. The last closing price for Rocket Pharmaceuticals was $20.85. Over the last year, Rocket Pharmaceuticals shares have traded in a share price range of $ 14.89 to $ 32.525.

Rocket Pharmaceuticals currently has 90,782,211 shares outstanding. The market capitalization of Rocket Pharmaceuticals is $10.89 million. Rocket Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.04.

RCKT Latest News

Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need...

Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Long-term KRESLADITM follow-up data demonstrate survival of 100% in the absence of allogeneic hematopoietic stem cell transplantation (HSCT) from 18 to 45 months with a well-tolerated safety...

Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress

Advanced RP-L102 for Fanconi Anemia towards regulatory reviews; EMA accepted MAA for review and BLA submission anticipated in the first half of 2024 Continued preparations to launch LV portfolio...

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia

Positive, previously disclosed results from the global Phase 1/2 trial demonstrated genetic and phenotypic correction combined with hematologic stabilization extending out to 42 months after...

Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team

Aaron Ondrey joins as Chief Financial Officer bringing seasoned leadership experience in financial management, strategic planning, commercial finance, and capital allocation Additional key...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.29-1.2866015971622.5422.6120.27566818021.08090622CS
40.381.7375400091421.8724.3820.17568925921.82426CS
12-4.74-17.562060022226.9926.9920.17564967922.92616328CS
26-6.31-22.09383753528.5632.52520.17570005226.19458635CS
52-0.11-0.49194991055522.3632.52514.8986365523.01314704CS
156-20.89-48.423736671343.1449.667.56575743920.83065518CS
2605.2731.036513545316.9867.487.56561243323.85117115CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AREBAmerican Rebel Holdings Inc
$ 0.7262
(141.26%)
292.36M
NXLNexalin Technologies Inc
$ 2.0799
(89.08%)
42.72M
SHCRSharecare Inc
$ 1.365
(76.27%)
35.41M
SPECSpectaire Holdings Inc
$ 0.5686
(67.24%)
59.23M
MINMMinim Inc
$ 3.8921
(36.09%)
41.87M
KAVLKaival Brands Innovations Group Inc
$ 1.485
(-48.26%)
3.33M
PBMPsyence Biomedical Ltd
$ 0.4004
(-33.27%)
2.24M
FLFVFeutune Light Acquisition Corporation
$ 5.81
(-31.08%)
38.48k
RELIReliance Global Group Inc
$ 0.460919
(-23.68%)
7.61M
FBLGFibroBiologics Inc
$ 4.17
(-22.06%)
280.9k
NVDANVIDIA Corporation
$ 127.39
(-2.59%)
300.61M
AREBAmerican Rebel Holdings Inc
$ 0.7278
(141.79%)
292.36M
CRKNCrown Electrokinetics Corporation
$ 0.041369
(-17.26%)
137.97M
NKLANikola Corporation
$ 0.368
(11.65%)
125.77M
ASTIAscent Solar Technologies Inc
$ 0.111174
(3.03%)
114.24M

RCKT Discussion

View Posts
Monksdream Monksdream 6 months ago
RCKT new 52 week high
👍️0
make it happen make it happen 9 months ago
How's it up 38% @ $21.00 PPS when diluting $175,000,000 million @ $16.00??
👍️0
trkyhntr trkyhntr 4 years ago
I have been away at hunting camp for a few weeks, and when I got back I was pleasantly surprised. This puppy has doubled! Any thoughts as to how much more upside there is?
👍️0
ClayTrader ClayTrader 4 years ago
* * $RCKT Video Chart 12-09-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Glider549 Glider549 4 years ago
Check out Seeking Alpha, January 27, article.
Lots of insider buying and Fast Track status.
👍️0
RUSTYJ RUSTYJ 5 years ago
How you figure a lot power , Gravity takes it down
👍️0
investor86 investor86 6 years ago
This got a lot of power!!
👍️0
trkyhntr trkyhntr 6 years ago
This is a new board for this stock. Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic that the Company has designed to lower intraocular pressure (IOP) by restoring the eye's natural pressure control mechanism. The Company developed this molecule to selectively stimulate a particular adenosine subreceptor in the eye with the effect of augmenting the intrinsic function of the eye's trabecular meshwork (TM). Its product pipeline includes trabodenoson monotherapy delivered in an eye drop formulation, as well as a fixed-dose combination (FDC), of trabodenoson with latanoprost given once-daily (QD). The Company is evaluating the potential of trabodenoson to slow the loss of vision associated with glaucoma and degenerative retinal diseases.
👍️0

Your Recent History

Delayed Upgrade Clock